CA2086258A1 - Vaccins d'anatoxine pasteurella multocida - Google Patents

Vaccins d'anatoxine pasteurella multocida

Info

Publication number
CA2086258A1
CA2086258A1 CA002086258A CA2086258A CA2086258A1 CA 2086258 A1 CA2086258 A1 CA 2086258A1 CA 002086258 A CA002086258 A CA 002086258A CA 2086258 A CA2086258 A CA 2086258A CA 2086258 A1 CA2086258 A1 CA 2086258A1
Authority
CA
Canada
Prior art keywords
pasteurella multocida
multocida
toxoid
toxoid vaccines
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002086258A
Other languages
English (en)
Other versions
CA2086258C (fr
Inventor
Joseph C. Frantz
David S. Roberts
Leroy A. Swearingin
Richard J. Kemmy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Joseph C. Frantz
David S. Roberts
Leroy A. Swearingin
Richard J. Kemmy
Smithkline Beecham Corporation
Pfizer Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Joseph C. Frantz, David S. Roberts, Leroy A. Swearingin, Richard J. Kemmy, Smithkline Beecham Corporation, Pfizer Inc. filed Critical Joseph C. Frantz
Priority to CA002312296A priority Critical patent/CA2312296C/fr
Priority claimed from PCT/US1991/004092 external-priority patent/WO1991019419A1/fr
Publication of CA2086258A1 publication Critical patent/CA2086258A1/fr
Application granted granted Critical
Publication of CA2086258C publication Critical patent/CA2086258C/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0241—Mollicutes, e.g. Mycoplasma, Erysipelothrix
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/099—Bordetella
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/285—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pasteurellaceae (F), e.g. Haemophilus influenza
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
CA002086258A 1990-06-13 1991-06-10 Vaccins d'anatoxine pasteurella multocida Expired - Lifetime CA2086258C (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA002312296A CA2312296C (fr) 1990-06-13 1991-06-10 Vaccins d'anatoxine pasteurella multocida

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US53745490A 1990-06-13 1990-06-13
US537,454 1990-06-13
PCT/US1991/004092 WO1991019419A1 (fr) 1990-06-13 1991-06-10 Vaccins contre l'anatoxine pasteurella multocida

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CA002312296A Division CA2312296C (fr) 1990-06-13 1991-06-10 Vaccins d'anatoxine pasteurella multocida

Publications (2)

Publication Number Publication Date
CA2086258A1 true CA2086258A1 (fr) 1991-12-14
CA2086258C CA2086258C (fr) 2007-10-23

Family

ID=38650016

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002086258A Expired - Lifetime CA2086258C (fr) 1990-06-13 1991-06-10 Vaccins d'anatoxine pasteurella multocida

Country Status (1)

Country Link
CA (1) CA2086258C (fr)

Also Published As

Publication number Publication date
CA2086258C (fr) 2007-10-23

Similar Documents

Publication Publication Date Title
CA2243755A1 (fr) Vaccin a base de peptidase c5a du streptocoque
CA2082155A1 (fr) Vaccin contre la pneumonie du porc et methode de preparation
HUT62467A (en) Process for producing locally applicable pharmaceutical compositions comprising allylamine derivative, against fungus infection of nails
CA2089552A1 (fr) Vaccin bacterien de mycoplasma hyopneumoniae inactivee et methode d'utilisation
CA2102036A1 (fr) Vaccins entrainant une reaction immunitaire contre la maladie causee par la souche iowa du virus associe au syndrome dysgenesique respiratoire porcin
LU91595I2 (fr) Combinaison d'anatoxine diphtérique, d'anatoxine tétanique, d'anatoxine coquelucheuse, d'hémagglutinine filamenteuse, de pertactine et de polyoside capsulaire d'haemophilus influenzae type b (InfanrixHib)
LU91924I2 (fr) Composition vaccinale comprenant le polysaccharidecapsulaire et Haemophilus influenzae type b coupl é à l'anatoxine tétanique, l'antigène diphtérique,l'antigène tétanique, des antigènes de la polio, des antigènes de la coqueluche et du phosphate d'aluminium
CA2040544A1 (fr) Vaccin de sous-unite actionobacillus pleuropneumoniae
AU8314587A (en) New oligosaccharides, immunogens and vaccines, and methods for preparing such oligosaccharides, immunogens and vaccines
AU1362895A (en) Pasteurella multocida toxoid vaccines
GR3017427T3 (en) Composition and method for protecting against diseases caused by microorganisms.
PL303482A1 (en) Vaccine against infection with streptococcus suis, streptococcus suis polypeptide and method of preparing such vaccine
WO1994010317A3 (fr) Vaccin conjugue contre des streptocoques du groupe b
NZ295238A (en) Immunogenic compositions characterised by the carrier being a hydrophobic solvent in the absence of a hydrophilic phase
NL990018I1 (nl) Vaccin tegen Pasteurella.
WO1997045139A3 (fr) IL-12 EN TANT QU'ADJUVANT POUR DES VACCINS CONTRE L'ESPECE $i(BORDETELLA PERTUSSIS)
WO1992006113A3 (fr) DERIVES DE gp160 ET VACCINS A BASE DE gp160 OU D'UN DE SES DERIVES, CONTENANT UN ADJUVANT
CA2075711A1 (fr) Vaccin et methode de fabrication
EP1074554A3 (fr) Dérivés de 7-acyl-3-(carbamoyloxy substitué)-céphème, leur application et leur procédé de préparation
MD1788F2 (en) Erythromycin A 9-O-oximes derivatives, pharmaceutical composition on base thereof and method of treatment of infectious diseases
CA2086258A1 (fr) Vaccins d'anatoxine pasteurella multocida
CA2312296A1 (fr) Vaccins d'anatoxine pasteurella multocida
EP0529019A4 (en) Nematode vaccine
CA2004206A1 (fr) Methodes de preparation de l'anatoxine coquelucheuse
GB9018061D0 (en) Compositions for vaccines

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry